JP2019501940A5 - - Google Patents

Download PDF

Info

Publication number
JP2019501940A5
JP2019501940A5 JP2018536503A JP2018536503A JP2019501940A5 JP 2019501940 A5 JP2019501940 A5 JP 2019501940A5 JP 2018536503 A JP2018536503 A JP 2018536503A JP 2018536503 A JP2018536503 A JP 2018536503A JP 2019501940 A5 JP2019501940 A5 JP 2019501940A5
Authority
JP
Japan
Prior art keywords
methyl
oxo
diazaspiro
phenyl
cis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018536503A
Other languages
English (en)
Japanese (ja)
Other versions
JP6854823B2 (ja
JP2019501940A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2017/025007 external-priority patent/WO2017121649A1/en
Publication of JP2019501940A publication Critical patent/JP2019501940A/ja
Publication of JP2019501940A5 publication Critical patent/JP2019501940A5/ja
Application granted granted Critical
Publication of JP6854823B2 publication Critical patent/JP6854823B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018536503A 2016-01-13 2017-01-13 3−(カルボキシメチル)−8−アミノ−2−オキソ−1,3−ジアザ−スピロ−[4.5]−デカン誘導体 Expired - Fee Related JP6854823B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16151014 2016-01-13
EP16151014.4 2016-01-13
PCT/EP2017/025007 WO2017121649A1 (en) 2016-01-13 2017-01-13 3-(carboxymethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives

Publications (3)

Publication Number Publication Date
JP2019501940A JP2019501940A (ja) 2019-01-24
JP2019501940A5 true JP2019501940A5 (enExample) 2020-02-20
JP6854823B2 JP6854823B2 (ja) 2021-04-07

Family

ID=55129635

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018536503A Expired - Fee Related JP6854823B2 (ja) 2016-01-13 2017-01-13 3−(カルボキシメチル)−8−アミノ−2−オキソ−1,3−ジアザ−スピロ−[4.5]−デカン誘導体

Country Status (29)

Country Link
US (7) US20170197971A1 (enExample)
EP (1) EP3402785B1 (enExample)
JP (1) JP6854823B2 (enExample)
KR (1) KR20180097733A (enExample)
CN (1) CN108779075B (enExample)
AR (1) AR107358A1 (enExample)
AU (1) AU2017206910B2 (enExample)
BR (1) BR112018014296B1 (enExample)
CA (1) CA3011180A1 (enExample)
CL (1) CL2018001910A1 (enExample)
CO (1) CO2018008449A2 (enExample)
CY (1) CY1122892T1 (enExample)
DK (1) DK3402785T3 (enExample)
EA (1) EA034904B1 (enExample)
EC (1) ECSP18060864A (enExample)
ES (1) ES2793384T3 (enExample)
HR (1) HRP20200809T1 (enExample)
HU (1) HUE049134T2 (enExample)
IL (1) IL260497B (enExample)
LT (1) LT3402785T (enExample)
MX (1) MX378995B (enExample)
PE (1) PE20181716A1 (enExample)
PL (1) PL3402785T3 (enExample)
PT (1) PT3402785T (enExample)
RS (1) RS60224B1 (enExample)
SI (1) SI3402785T1 (enExample)
TW (1) TWI640514B (enExample)
WO (1) WO2017121649A1 (enExample)
ZA (1) ZA201805358B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6893517B2 (ja) 2016-01-13 2021-06-23 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 3−((ヘテロ−)アリール)−アルキル−8−アミノ−2−オキソ−1,3−ジアザ−スピロ−[4.5]−デカン誘導体
TWI635082B (zh) 2016-01-13 2018-09-11 歌林達有限公司 3-((雜-)芳基)-8-胺基-2-側氧-1,3-二氮雜-螺-[4.5]-癸烷衍生物
DK3402783T3 (da) 2016-01-13 2020-05-04 Gruenenthal Gmbh 3-(carboxyethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decan-derivater
MX378995B (es) 2016-01-13 2025-03-11 Gruenenthal Gmbh Derivados de 3-(carboximetil)-8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano.
RS60855B1 (sr) 2016-01-13 2020-10-30 Gruenenthal Gmbh Derivati 8-amino-2-okso-1,3-diaza-spiro-[4.5]-dekana
WO2019039855A2 (ko) 2017-08-22 2019-02-28 주식회사 엘지화학 방열 소재의 혼합 방법
US20240400537A1 (en) 2023-04-25 2024-12-05 Gruenenthal Gmbh Cis-8-(3,5-difluorophenyl)-8-(dimethylamino)-1,3-diazaspiro[4.5]decan-2-one derivatives

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2734265B1 (fr) 1995-05-17 1997-06-13 Adir Nouveaux composes spiro heterocycliques, leur procede de preparation et les compositions pharmaceutiques les contenant
RU2268883C2 (ru) 2001-04-18 2006-01-27 Эро-Селтик, С.А. Аналоги ноницептина и фармацевтическая композиция на их основе
DE10130020A1 (de) 2001-06-25 2003-12-04 Gruenenthal Gmbh Substituierte 1-Oxa-2,8-diaza-spiro[4.5]dec-2-en-derivate
DE10210195B4 (de) 2002-03-07 2005-12-15 Schwarz Pharma Ag Verwendung von 1,3-Diazaspiro-[4,5]decan-2,4-dithion zur Behandlung von Schmerz
PT1519939E (pt) 2002-07-05 2010-02-10 Targacept Inc Compostos n-arildiazaspirocíclicos e métodos para a sua preparação e utilização
DE10252667A1 (de) * 2002-11-11 2004-05-27 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
ZA200510329B (en) 2003-05-23 2007-04-25 Zealand Pharma As Triaza-spiro compounds as nociceptin analogues and uses thereof
JO2676B1 (en) 2004-04-06 2012-06-17 جانسين فارماسوتيكا ان. في Derivatives of second-aza-spiro- (5,4) -dikan and their use as antihistamines
DE102005044813A1 (de) 2005-05-19 2007-10-04 Grünenthal GmbH Substituierte Spiro-Verbindungen und deren Verwendung zur Herstellung von Arzneimitteln
DE102005023784A1 (de) 2005-05-19 2006-11-30 Grünenthal GmbH Substituierte Spiro-Verbindungen und deren Verwendung zur Herstellung von Arzneimitteln
DE102005030051A1 (de) 2005-06-27 2006-12-28 Grünenthal GmbH Substituierte 1-Oxa-3,8-diazaspiro[4,5]-decan-2-on-Verbindungen und deren Verwendung zur Herstellung von Arzneimitteln
DE102006019597A1 (de) 2006-04-27 2007-10-31 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
AU2007312391B2 (en) 2006-10-19 2012-06-21 F. Hoffmann-La Roche Ag Imidazolone and imidazolidinone derivatives as 11b-HSD1 inhibitors for diabetes
EP2150552B1 (en) 2007-04-09 2013-01-02 Janssen Pharmaceutica NV 1,3,8-trisubstituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as ligands of the orl-i receptor for the treatment of anxiety and depression
KR20120075500A (ko) * 2008-03-27 2012-07-06 그뤼넨탈 게엠베하 치환된 4-아미노사이클로헥산 유도체
TW201038572A (en) 2009-03-25 2010-11-01 Gruenenthal Gmbh Substituted spiro-amide compounds
US8268853B2 (en) 2009-06-25 2012-09-18 Abbott Laboratories 3,9-diazaspiro[5,5]undecane amides and ureas and methods of use thereof
TWI582092B (zh) * 2010-07-28 2017-05-11 歌林達股份有限公司 順式-四氫-螺旋(環己烷-1,1’-吡啶[3,4-b]吲哚)-4-胺-衍生物
EP3154971A4 (en) * 2014-06-13 2017-11-01 Purdue Pharma L.P. Heterocyclic morphinan derivatives and use thereof
TWI730032B (zh) 2016-01-13 2021-06-11 美商必治妥美雅史谷比公司 作為rock抑制劑之螺庚烷水楊酸醯胺及相關化合物
JP6893517B2 (ja) 2016-01-13 2021-06-23 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 3−((ヘテロ−)アリール)−アルキル−8−アミノ−2−オキソ−1,3−ジアザ−スピロ−[4.5]−デカン誘導体
TWI635082B (zh) 2016-01-13 2018-09-11 歌林達有限公司 3-((雜-)芳基)-8-胺基-2-側氧-1,3-二氮雜-螺-[4.5]-癸烷衍生物
MX378995B (es) 2016-01-13 2025-03-11 Gruenenthal Gmbh Derivados de 3-(carboximetil)-8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano.
RS60855B1 (sr) 2016-01-13 2020-10-30 Gruenenthal Gmbh Derivati 8-amino-2-okso-1,3-diaza-spiro-[4.5]-dekana
DK3402783T3 (da) 2016-01-13 2020-05-04 Gruenenthal Gmbh 3-(carboxyethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decan-derivater
RU2747877C2 (ru) 2016-01-13 2021-05-17 Ново Нордиск А/С Аналоги эфр(а) с заместителями - жирными кислотами

Similar Documents

Publication Publication Date Title
HRP20200809T1 (hr) Derivati 3-(karboksimetil)-8-amino-2-okso-1,3-diaza-spiro-[4.5]-dekana
JP6505013B2 (ja) スルファモイル−アリールアミド及びb型肝炎の治療のための薬剤としてのその使用
JP2019501936A5 (enExample)
JP2021529812A5 (enExample)
WO2024034593A1 (ja) G12v変異krasタンパクの分解を誘導するための複素環化合物
JP2021507895A5 (enExample)
ES2609987T3 (es) Piridinonas bicíclicas novedosas
JP2013520502A5 (enExample)
JP2021533110A (ja) 癌免疫療法剤としての新規エクトヌクレオチドピロホスファターゼ/ホスホジエステラーゼ−1(ENPP1)の置換3H−イミダゾ[4,5−c]ピリジンおよび1H−ピロロ[2,3−c]ピリジンシリーズならびにインターフェロン遺伝子刺激因子(STING)調節剤
TW201524964A (zh) 治療活性化合物及其使用方法(一)
JP2017535525A5 (enExample)
JP2023531709A5 (enExample)
SG172452A1 (en) Oxadiazole derivatives as slpl receptor agonists
CN105473560B (zh) 治疗活性化合物及其使用方法
JP2011500562A5 (enExample)
JP2006501176A5 (enExample)
JP2018505880A5 (enExample)
JP2016516724A5 (enExample)
WO2014145028A2 (en) N-acyl-n'-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities
JP2016514117A5 (enExample)
JP2013544276A5 (enExample)
JP2014531441A5 (enExample)
JP2019537559A5 (enExample)
JP2014500330A5 (enExample)
EP4196125A1 (en) Compounds, compositions and methods